Urinary Incontinence Device Market Expected to Reach $6.17 Billion by 2030—Allied Market Research

According to a new report published by Allied Market Research, titled, “Urinary Incontinence Device Market, by Product, Category, Incontinence Type, and End User: Global Opportunity Analysis and Industry Forecast, 2021–2030," the global urinary incontinence device market was valued at $2.1 billion in 2020 and is projected to reach $6.2 billion by 2030 registering a CAGR of 11.8% from 2021 to 2030.

Urinary incontinence is a highly prevalent condition and is considered to be an underreported problem that increases with age that affects nearly 50% of the geriatric population. It is categorized into four major types namely stress urinary incontinence, urge urinary incontinence, mixed urinary incontinence, and functional urinary incontinence. Stress urine leakage is associated with increased abdominal pressure from laughing, sneezing, coughing, climbing stairs, or other physical factors that assert stress on the abdominal cavity. Whereas, urge incontinence is the involuntary leakage accompanied by urgency. Among the four above mentioned types of urinary incontinence; stress and urge are commonly prevalent among men and women.

Urinary incontinence has a major impact on the emotional, psychological, and social life; maximum number of patients suffering from urinary incontinence cannot perform regular activities confidently. This propels the development of effective solutions for the treatment of the same. According to the Urology Care Foundation, a quarter to a third of men and women in the U.S. suffer from urinary incontinence per year. This also indicates that approximately 33 million of the U.S. residents have overactive bladder that represent symptoms of urgency and frequency.

Some of the other factors responsible for substantial market growth include rise in demand for minimally invasive procedures, development of innovative urinary incontinence devices, increase in aging population coupled with high risk of urological conditions, and increase in the urinary incontinent patients transitioning from conventional solutions to advanced surgical treatments. Factors such as lack of awareness regarding novel developments in the urinary incontinence devices and post-operative complications associated with the devices restrict the market growth to a certain extent. 

Moreover, growth in healthcare expenditures in the developing economies offers lucrative opportunities for the market players to invest in these economies.

COVID-19 is a large family of viruses that causes illness ranging from common cold to more severe respiratory diseases. The COVID-19 pandemic has limited the industry growth significantly, as the demand for urinary incontinence device decreased owing to decline in diagnostics and surgical procedures in the first half of 2020. According to the study published in the British Journal of Surgery, around 28.4 million elective procedures were cancelled or postponed in May 2020, based on a 12-week period of peak disruption to hospital services due to COVID-19. Thus, the outbreak of COVID-19 has negatively impacted the urinary incontinence device market.

The urinary incontinence devices market is segmented on the basis of product, category, incontinence type, end user, and region. By product, the market is divided into urinary catheters, vaginal slings, electrical stimulation devices, artificial urinary sphincters, and other devices. The urinary catheters segment is further bifurcated into foley catheters and other urinary catheters. Whereas, vaginal slings segment is sub segmented into conventional vaginal slings and advanced vaginal slings. On the basis of category, it is classified into external urinary incontinence devices and internal urinary incontinence devices. By incontinence type, the urinary incontinence device market is divided into stress incontinence, urge incontinence, overflow incontinence, and functional incontinence. Further, by end user, it is classified into hospitals, clinics, and other. By region, the urinary incontinence device market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

By product, the vaginal slings segment generated the highest revenue in 2020, accounting for 14.10 % of the total market. This is attributed to the high contribution of the conventional vaginal slings in the vaginal slings market owing to the high preference for the use of biomaterials in surgical treatment of incontinence. Advancements in the conventional vaginal slings assist in eliminating the post-operative complications associated with the vaginal sling surgeries and several key players are developing conventional using advanced synthetic materials to meet the patient’s requirement. In addition, the advanced vaginal slings have witnessed increased adoption in the surgical treatment of urinary incontinence among women owing to their minimal invasive nature.

By category, the internal urinary incontinence devices segment generated the highest revenue in 2020 and is anticipated to continue this trend throughout the forecast period. This is attributed to the increase in focus on the development of vaginal slings along with rise in demand for internal urethral devices.

By incontinence type, the stress incontinence segment generated the highest revenue in 2020 accounting for 11.90% of the total share of the urinary incontinence device market and is anticipated to continue this trend throughout the forecast period. Pregnancy as well as childbirth results in the stretching and weakening of a woman’s pelvic floor muscles, which causes stress urinary incontinence. In addition, prostate surgeries in men can also result in stress urinary incontinence. This has made stress urinary incontinence the most prevalent conditions among men and women.

By end user, the hospital segment dominated the global urinary incontinence device market in 2020 and is anticipated to continue this trend during the forecast period. This was attributed to the fact that, urinary incontinence most commonly affects women and the prevalence is high among hospitalized older adults. Thus, hospitals have displayed maximum adoption of the urinary incontinence devices a lot of patients suffering from chronic conditions or pregnancy are associated with urinary incontinence.

The key players in this market have adopted product launch as one of their key developmental strategies such as acquisitions and product launches. The major companies profiled in this report include Becton, Dickinson and Company (C.R. Bard Inc.), Boston Scientific Corporation, Caldera Medical, Coloplast A/S, ConvaTec Group plc, Cook Group Inc. (Cook Medical Inc.), Johnson & Johnson (Ethicon Inc.), Laborie Medical (Cogentix Medical Inc.), Medtronic plc, and Teleflex Incorporated.

KEY FINDINGS OF THE STUDY 

• By device, the vaginal slings segment held largest share in the global urinary incontinence device market in 2020.
• By category, the internal urinary incontinence devices segment held largest share in the global urinary incontinence device market in 2020.
• By incontinence type, the stress incontinence segment held the largest market share in 2020 and is expected to remain dominant throughout the forecast period. 
• By end user, the hospital segment dominates the global urinary incontinence device market in 2020 and is anticipated to continue this trend during the forecast period.
• By region, North America is expected to experience growth at the highest rate, registering a CAGR of 10.80 % during the forecast period. 

The North American urinary incontinence devices market accounted for the highest market share and is expected to continue its dominance throughout the forecast period. This is primarily due to the early adoption of novel urinary incontinence devices along with increase in prevalence of stress urinary incontinence among women in this region. Whereas, Asia-Pacific is anticipated to grow at the fastest pace as high geriatric population base (more susceptible to urinary incontinence) is witnessed in this region.